Link Pharma Chem Limited , a chemicals manufacturer, has released its unaudited financial results for the second quarter and first half of the fiscal year 2026, along with an announcement of a key personnel change.

Financial Performance

The company reported a mixed financial performance for the quarter ended September 30, 2025:

For the half-year period:

The company's revenue from operations saw a decline in the second quarter compared to the same period last year. However, the half-yearly revenue showed a slight increase.

Management Change

The Board of Directors has accepted the resignation of Ms. Khushbu Prakashbhai Patel from her position as Company Secretary and Compliance Officer. Her resignation will be effective from December 16, 2025. The company stated that Ms. Patel is leaving to pursue better prospects outside the organization.

Company Overview

Link Pharma Chem Limited operates in the manufacture and sale of chemicals segment.

Financial Trends

Looking at the broader financial picture:

The company has shown some improvement in its net loss position and operating profit margin compared to the previous fiscal year, despite a decrease in annual revenue.

Link Pharma Chem Limited, a pharmaceutical company listed on the Bombay Stock Exchange (BSE: 524748), held its 40th Annual General Meeting (AGM) on September 9, 2025, where shareholders approved several key resolutions, including the re-appointment of Mrs. Rachna Manav Ghai as a Woman Independent Director.

Re-appointment of Independent Director

The shareholders approved the re-appointment of Mrs. Rachna Manav Ghai (DIN: 08885422) as a Woman Independent Director for a second term of five consecutive years, effective from September 14, 2025, to September 13, 2030. This special resolution was passed with unanimous support from both promoter and public shareholders.

Director's Profile

Mrs. Ghai brings a wealth of experience to the board:

• Educational Background: First-class Bachelor of Science degree (1997) and Post Graduate Diploma in Business Management (PGDBM) (1998)
• Areas of Expertise: Education and general administration
• Independence: Meets the criteria of independence as prescribed under the Companies Act, 2013 and SEBI regulations
• Relationship with Company: Not related to any Directors, Key Managerial Personnel, or Promoters of Link Pharma Chem Limited

AGM Highlights

The 40th AGM, conducted through Video Conferencing (VC) and Other Audio-Visual Means (OAVM), saw the participation of 44 members, including corporate representatives. Key points from the meeting include:

1. Adoption of financial statements for the year ended March 31, 2025
2. Re-appointment of Mr. Rishikesh Thakur (DIN: 08777265) as a director
3. Ratification of remuneration for Cost Auditors for the financial year 2025-2026

Voting Results

All resolutions presented at the AGM were passed with the requisite majority. The e-voting results showed strong support from both promoter and public shareholders:

The meeting, which commenced at 11:40 AM, concluded at 12:10 PM, with Mr. Rishikesh Thakur, Managing Director, chairing the proceedings in place of Mr. Satish Thakur, who was unable to attend due to health reasons.

Link Pharma Chem Limited continues to demonstrate its commitment to corporate governance and shareholder engagement through these proceedings, ensuring transparency and compliance with regulatory requirements.